登录

Rentschler Biopharma任命Patrick Cushing为美国子公司运营副总裁

Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary

GlobeNewswire | 2024-05-02 | 翻译由动脉网AI生成,点击反馈

可切换为仅中文


LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, May 02, 2024 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced that Patrick Cushing, Ph.D., has been promoted to Vice President Operations of Rentschler Biopharma, Inc., the company’s U.S.

2024年5月2日,德国劳菲姆(LAUPHEIM)、马萨诸塞州米尔福德(MILFORD)和英国史蒂夫纳格(STEVENAGE)(环球通讯社)——全球领先的生物制药合同开发和制造组织(CDMO)Rentschler Biopharma SE今天宣布,帕特里克·库欣(PatrickCushing)博士已晋升为该公司美国分公司Rentschler Biopharma,Inc.的运营副总裁。

subsidiary, effective May 1, 2024. In this newly created position, Dr. Cushing will oversee and manage all operational processes at the site and report to Rentschler Biopharma’s Chief Operating Officer, Christiane Bardroff. Christiane Bardroff, Chief Operating Officer at Rentschler Biopharma, commented: “The appointment of Patrick Cushing to Vice President Operations at our state-of-the-art manufacturing site in Milford reflects our commitment to delivering the highest quality services to our clients.

子公司,自2024年5月1日起生效。在这个新成立的职位上,库欣博士将监督和管理现场的所有运营流程,并向Rentschler Biopharma的首席运营官克里斯蒂安·巴德罗夫(ChristianeBardroff)报告。Rentschler Biopharma首席运营官克里斯蒂安·巴德罗夫(ChristianeBardroff)评论道:“帕特里克·库欣(PatrickCushing)被任命为米尔福德(Milford)最先进的生产基地运营副总裁,这反映了我们致力于为客户提供最高质量的服务。

His unwavering dedication aligns perfectly with our vision of advancing medicine to save lives. The creation of this new position recognizes many important milestones we have achieved during the last months, with new manufacturing lines coming online at our U.S. facility. Patrick brings exceptional leadership skills to this role, having consistently demonstrated his ability to work not only with his team and across departments but also with colleagues from other Rentschler Biopharma sites to develop and manufacture a broad range of innovative therapies.

他坚定不移的奉献精神与我们推进医学拯救生命的愿景完全一致。这一新职位的设立标志着我们在过去几个月取得了许多重要的里程碑,新的生产线将在我们的美国工厂上线。帕特里克为这一角色带来了非凡的领导技能,他一直证明自己不仅有能力与团队和跨部门合作,而且有能力与其他Rentschler生物制药公司的同事合作,开发和制造广泛的创新疗法。

In his new role, he will serve to further streamline and strengthen the organization as we support existing and new clients in the U.S.” Patrick Cushing, Vice President Operations at Rentschler Biopharma, Inc., said: “I am excited to take on this new role as we significantly expand our capacity in the U.S.

Rentschler Biopharma,Inc.运营副总裁帕特里克·库欣(PatrickCushing)表示:“在我们为美国现有客户和新客户提供支持的过程中,他将在新的岗位上进一步精简和加强该组织,我很高兴担任这一新角色,因为我们大大扩展了在美国的能力。

At Rentschler Biopharma, we are truly one team. In my n.

在Rentschler Biopharma,我们真的是一个团队。在我的n。

推荐阅读

Rentschler Biopharma任命Senta Brandt为全球转型主管、Gerrick Rodrigues为全球信息技术主管

BioSpace 2024-02-06 22:36

Rentschler Biopharma SE任命Gunnar Voss von Dahlen为首席财务官,并完成执行董事会

GlobeNewswire 2023-12-07 17:00

GEN 2023-09-14 08:45

GlobeNewswire

8153篇

最近内容 查看更多

飞利浦在心律年会上展示研究结果,展示其人工智能心脏监测解决方案的优势

5 小时后

QuTEM获得瑞典医疗产品管理局颁发的透射电子显微镜实验室GMP证书和生产许可证

3 小时后

Erasca宣布RAS特许经营战略许可

3 小时前

相关公司查看更多

Rentschler Biopharma

合同开发和制造组织(CDMO)公司

立即沟通

产业链接查看更多

所属赛道

研发制造外包
近30天,融资3起
动脉橙产业智库梳理了:国内生物医药CXO相关公司以及投融资和并购事件400+;近几年披露的融资总额约90.73亿美元;产业图谱、资本风云与相关政策等分析维度,将持续更新。
CDMO